CDKN2A and cancer: Indeed, several studies report that completion of primary cancer therapy (post-treatment) accelerates biological aging in cancer survivors, as evidenced by increased expression of cytokines (12, 13), senescence-associated p16INK4 (13), and decreased telomere length (14).